Loading
HP
Heratsi Pharmaceuticals Stock: price and insider trades · United States
Heratsi Pharmaceuticals: what insiders have been doing
We have very little insider data for Heratsi Pharmaceuticals so far: the most recent filing dates from 16 November 2007. With so few records, no pattern can be drawn yet. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.
Insider Decl.
1
Thresholds
n/a
Buy Volume
n/a
n/a
Sell Volume
n/a
n/a
Financial data
· cache
Last declaration on 16 November 2007
Declarations1 total
14,000,000 shares0Common Stock, par value $.0001 per share(the "Common Stock")SEC:0001144204-07-062422:0
1 of 1 declaration
About Heratsi Pharmaceuticals
Heratsi Pharmaceuticals is a NASDAQ-listed pharmaceutical company focused on the development and commercialization of innovative medications. It specializes in treatments for various chronic and acute diseases.
